IMA Stock Price, News & Analysis

IMA

Company Description

Welcome to the overview page for IMA (IMA), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

- %

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Latest News

View All

yesterday

0.00%

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

private placement acquisition

SEC Filings

View All

No SEC filings available for IMA.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

July 28, 2025

Trading commencement

Merged entity begins trading on Nasdaq under ticker IMA

July 28, 2025

Reverse stock split effective

1-for-12 reverse split of Ikena common stock concurrent with merger

October 1, 2026 - December 31, 2026

Phase 2b topline data

Topline data for IMG-007 in atopic dermatitis expected